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Background: Bone-related complications are commonly reported in cancer patients receiving radiotherapy and are
collectively referred to as the abscopal effect of irradiation, the mechanism of which remains poorly understood.
When patients receive targeted radiotherapy to a tumor, the local skeleton is exposed to radiation, particularly within
the bone marrow. We therefore investigated the hypothesis that single bone irradiation can induce deterioration of
the skeleton outside the radiation field and is mediated by the bone marrow.
Methods: Using 4-month-old male Sprague-Dawley rats, the effects of irradiation (20 Gy, right distal femur and
proximal tibia) on bone quality, microarchitecture and bone marrow, were evaluated prospectively by microcomputed
tomography, histomorphometry, real-time polymerase chain reaction, and Western blot analysis.
Results: At 12 weeks post-irradiation, bone loss of the non-irradiated bone was induced and marrow adiposity was
increased. Expression of runt-related transcription factor-2 by bone mesenchymal stem cells (BMSCs) decreased after
irradiation by 88.0 % (P < 0.01) at the contralateral and 82.3 % (P < 0.01) at the irradiation site 2 weeks post-irradiation
and decreased by 94.5 % (P < 0.001) at the contralateral and 44.1 % (P < 0.05) at the irradiation site 12 weeks
post-irradiation. Interestingly, peroxisome proliferator-activated receptor gamma expression decreased by 61.8 % (P < 0.05)
at the contralateral and by 48.3 % (P < 0.05) at the irradiation site 2 weeks post-irradiation but increased by 9-fold at the
contralateral (P < 0.001) and by 13-fold (P < 0.001) at the irradiation site 12 weeks post-irradiation.
Conclusions: These data highlight that radiation-induced bone complications are partly BMSC-mediated, with
important implications for bone health maintenance in patients receiving radiotherapy.
Keywords: Irradiation, Abscopal effect, Marrow adiposity, BMSCs, Runx2, PPAR γBackground
Following the discovery of X-rays by the German physicist
Wilhelm Conrad Roentgen, radiation was used to treat
cancer patients and has since been proven as an effective
treatment [1, 2]. However, the side effects of irradiation
come at the expense of normal tissue injury, especially
with the widespread use of radiotherapy in cancer patients
[3, 4]. Local irradiation is known to be a common treat-
ment for malignancies such as prostate, pancreatic, cer-
vical, rectal, and endometrial cancers, and with direct
irradiation exposure to the bone being inevitable, adverse
effects of irradiation on the skeleton are common [5–8].* Correspondence: xiaoyaxu@fudan.edu.cn
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(http://creativecommons.org/publicdomain/zeThe frequently reported skeletal complications after local
irradiation include regional and systemic osteopenia,
osteoporosis, osteonecrosis, and non-malignancy fracture,
all of which can seriously reduce the life quality of cancer
survivors [9, 10]. Diagnosis of these skeletal complications
is often prompted by patient pain at the affected bones.
The median time for a fracture diagnosis is between 6 and
16.9 months for female patients treated with radiotherapy
for pelvic malignancies when acute syndrome of irradi-
ation is not observed [9, 11, 12]. During this prolonged
time after irradiation, the mechanisms by which accumu-
lated changes in the bone occur without irradiation expos-
ure are not clear and appear to be multifactorial. A typical
treatment regimen of ionizing radiation for gynecological
cancers consists of administration of up to 60 Gy fraction-
ated over a 6-week span [13, 14]. Healthy by-standingdistributed under the terms of the Creative Commons Attribution 4.0
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this dose (~30 Gy) [14, 15]. The effects of radiation on the
bone have been typically characterized using total-body ir-
radiation models where widespread systemic inflammation
and radiation-induced hypogonadism can complicate data
interpretation with regard to the bone. In this present
study, we tested the hypothesis that single bone irradiation
can induce the deterioration of the skeleton outside the
radiation field. Analyses were performed at two time
points (2 and 12 weeks) after irradiation.Methods
Ethical approval
The experiment procedure and isolation of primary rat
bone mesenchymal stem cells (BMSCs) were carried out
in accordance with the Institutional Animal Ethics
Committee.Animal treatment
Male Sprague-Dawley rats (Shanghai Lab Animal Re-
source Center, STCSM, Shanghai, China) were used for
experiments at 4 months of age. Rats in the irradiated
group (n = 40) were anesthetized with ketamine and
placed into a 137Cs γ-ray irradiation chamber and ex-
posed to 20 Gy (0.8 Gy/min for 25 min, 137Cs γ-ray ir-
radiation machine) of the right limb of a 2 cm by 2 cm
area covering the proximal tibia and distal femur. Non-
irradiation body parts including the skeleton were
shielded with a custom-made plumbum block and contra-
lateral sides of the femur and tibia (bone which did not re-
ceive radiation but was removed from irradiated rats)
served as areas distant from irradiation. Control rats (n =
40) were similarly manipulated, anesthetized, and under-
went sham irradiation (0 Gy). All experiments involving
animals were performed according to institutionally ap-
proved and current animal care guidelines.Micro-CT analysis
Micro-CT analysis of the femur was studied by SkyScan-
1176 microcomputed tomography (μCT, Bruker micro
CT, Belgium) system. Scans were performed using
PANalytical’s Microfocus Tube, 17.93 μm voxel size,
65 KV, 385 μA, and 0.5° rotation step (180° angular
range). Micro-CT evaluation of the trabecular bone was
performed on a 2-mm region of metaphyseal spongiosa
in the distal femur. The regions were located 0.5 mm
above the growth plate. Measurements of the cortical
bone were performed on a 1-mm region of the middia-
physis of the femur. The 1.6 version of NR econ software
was used for 3D reconstruction and viewing of images.
After 3D reconstruction, the 1.13 version of CT software
was used for bone analysis.Bone mineral density analysis
Densitometry was performed by a dual-energy X-ray
absorptiometery (DXA) using high-resolution scans on
the femur and tibia. In brief, the isolated femurs and
tibias were placed on the same location on the platform
of a dual-energy X-ray absorptiometer (Discovery A,
Hologic Inc., Bedford, MA, USA) and scanned using
high-resolution imaging adapted for bone mineral dens-
ity (BMD) measurement of small animal skeletal subre-
gions according to the manufacturer’s instruction.Bone biomechanical quality evaluation
The biomechanical quality was evaluated by the three-
point bending test (femur). The tests were performed
on an electronic universal material testing machine
(INSTRON-5543, USA) using Merlin software accord-
ing to the manufacturer’s instruction. The maximum
load of the femur was obtained automatically from the
load-strain curve in the three-point bending test with a
span of 18 mm and a loading speed of 10.0 mm/min.Histological examination and histomorphometry
The tibia sections were stained with hematoxylin and
eosin (H&E), Oil red O, and Mayer’s hematoxylin and
histochemically for alkaline phosphatase (ALP) activity
using BCIP/NBT kit (Beyotime Biotechnology, China)
and tartrate-resistant acid phosphatase (TRAP) activity
using TRACP kit (Sigma, USA), respectively. The sec-
tions were then counterstained with methyl green and
mounted in Kaiser’s glycerol jelly. The following parame-
ters were measured: the ALP-positive osteoblast surface
per bone surface (OB.S/BS, %) for bone formation, the
TRAP-positive osteoclast surface per bone surface
(OC.S/BS, %) for bone resorption, and the adipocyte area
per bone marrow area without trabecula (%) for marrow
adiposity [16]. Images of micrographs from single sec-
tions were digitally recorded using a rectangular tem-
plate, and recordings were processed and analyzed using
Image Pro Plus image analysis software (Image Pro Plus,
version 4.112, Media Cybernetics, LP, USA).ELISA measurement of bone turnover markers in serum
Blood was collected at 2 and 12 weeks post-irradiation;
serum from each rat was analyzed individually in dupli-
cate for the bone formation marker osteocalcin (OCN)
using the Rat Osteocalcin EIA Kit (Immunodiagnostic
Systems Inc., England); and bone resorption was exam-
ined with the marker tartrate-resistant acid phosphatase
5b (TRAP5b) using the Rat TRAP Assay (Immunodiag-
nostic Systems Inc., England), following the instructions
of the manufacturers. The average value of the duplicate
measurements was obtained for each rat.
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Bone mesenchymal stem cells (BMSCs) of the tibia and
femur 2 and 12 weeks after irradiation were flushed out
with a-MEM (Gibco BRL, Carlsbad, CA); cells were
seeded on 100 mm culture dishes (Nunc, Rochester, NY)
and cultured in L-DMEM supplemented with 100 IU/ml
penicillin, 100 mg/ml streptomycin (Gibco BRL), and
10 % fetal bovine serum (FBS, Gibco BRL). Medium was
replaced every 3–4 days to remove no-adherent
hematopoietic cells. After 2 weeks, the adherent cells
were collected and sorted by flow cytometry with CD29,
CD90, CD34, and CD45. The sorted BMSCs (CD29+,
CD90+, CD34−, CD45−) were cultured in fresh medium
and further subcultured. The first passage of sorted
BMSCs was termed passage 1. BMSCs between passages
3 and 5 were used for experiments.
Quantitative real-time PCR
Passage 3 BMSCs were collected, and the total RNA was
extracted with Trizol reagent (15596; Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. Total RNA
was reversely transcribed to complementary DNA (cDNA)
using the QuantiTect Rev Transcription Kits (205311;
Qiagen, Chatsworth, CA). The number of cDNA mole-
cules in the reverse-transcribed samples was determined
by real-time PCR analyses using a modified method with
QuantiTect SYBR Green PCR Kits (204143, Qiagen) on
the Mx3000P Real-Time PCR system (Stratagene, La
Jolla, CA). The primers were obtained from SBSgene
(www.sbsgene.com) with the following sequences:
Runx2, 5′-AGCCTCTTCAGCGCAGTGAC-3′ and 5′-
CTGGTGCTCGGATCCCAA-3′ (132 bp, AF187319);
PPAR γ, 5′-TCAGGTTTGGGCGAATGC-3′ and 5′-
TTTGGTCAGCGGGAAGGA3′ (152 bp, Nm013124.3);
and GAPDH,5′-AAACCCATCACCATCTTCCA-3′ and
5′-GTGGTTCACACCCATCACAA-3′ (198 bp, DQ40
3053), using the protocol as previously described [17]. The
conditions were 12.5 μL of master SYBR green I, 0.25 μM
of each 5′ and 3′ primer, and 2 μL of samples and/or H2O
to a final volume of 25 μL. A melting curve was obtained at
the end of each run to discriminate specific from nonspe-
cific cDNA products. Content of cDNA was normalized
by subtracting the cycle numbers of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) from the target gene
(ΔCt =Ct of target gene −Ct of GAPDH), and gene expres-
sion level was calculated using 2−(ΔCt).
Western blotting analysis
Passage 5 BMSCs were collected and lysed with RIPA
buffer (P0013B; Beyotime, Jiangsu, China). Cells were ex-
tracted for 20 min on ice. Insoluble materials were re-
moved by centrifuging at 12,000rpm for 30 min, the
supernatants were collected, and protein amount was
then quantified with the BCA protein assay (P0012,Beyotime) using BSA as a standard. The sample protein
was denatured in boiling water for 5 min in SDS-PAGE
sample loading buffer (P0015, Beyotime). Aliquots of
samples (40 μg) were then subjected to SDS-PAGE in
12 % gels under reducing conditions and electroblotted
onto PVDF membranes (Ipvh00010; Millipore, Bedford,
MA). The membranes were blocked with 5 % fat-free
dry milk in tris-buffered saline and tween (TBST) (0.1 %
Tween-20 and 0.1 M NaCl in 0.1 M Tris-HCl, pH 7.5)
for 2 h at room temperature and with 1:500 goat anti-
Runx2 antibody (ab56326; Abcam, Cambridge, MA) or
1:1500 rabbit anti-PPAR γ antibody (AT819, Beyotime)
or 1:5000 mouse anti-GAPDH antibody (Kangcheng,
Shanghai, China) at 4 °C overnight. Membranes were
then incubated with horseradish peroxidase-conjugated
secondary antibody (1:5000; Santa Cruz Biotechnology,
Santa Cruz, CA) at room temperature for 1 h, followed
by chemiluminescence detection (P0018, Beyotime).
Each incubation step was followed by three washes
(10 min each) with TBST. The protein bands were quan-
titatively analyzed by using an image analysis system
(QuantityOne software; BioRad, Hercules, USA).
Statistical analysis
Differences were determined by one-way ANOVA, with
Bonferroni post hoc testing, or by the paired or unpaired
Student t test, as appropriate (GraphPad, Prism 6, ver-
sion 6.0c). Results are expressed as means ± standard de-
viations, and P < 0.05 was considered significant.
Results
Bone microarchitecture changed after single radiation
μCT was used to delineate a purely trabecular region of
interest such as changes in bone volume and microarchi-
tectural structure. Twelve weeks post-irradiation (20 Gy),
trabecula BMD (tBMD) of the femur was reduced by
18.1 % (P < 0.05) at the contralateral femur and by 21.2 %
(P < 0.05) at the irradiated femur relative to control
(Fig. 1a, b); trabecular bone volume fraction (BV/TV)
was reduced by 23.2 % (P < 0.05) at the contralateral
femur and by 30.8 % (P < 0.05) at the irradiated femur
relative to the control femur (Fig. 1d). The ratio of bone
surface to the bone volume (BS/BV) was increased by
20.4 % (P < 0.05) at the contralateral femur and by
32.9 % (P < 0.05) at the irradiated femur compared to
the control group (Fig. 1c). Trabecular thickness
(Tb.Th) and trabecular number (Tb.N) were reduced
significantly at 12 weeks after irradiation, Tb.Th was re-
duced by 12.1 % (P < 0.05) at the contralateral femur
and by 17.5 % (P < 0.05) at the irradiated femur; mean-
while, Tb.N was reduced by 16.1 % (P < 0.05) at the
contralateral femur and by 18.1 % (P < 0.05) at the irradi-
ated femur relative to control (Fig. 1e, f ). Trabecular
separation (Tb.Sp) was increased sharply after irradiation
Fig. 1 Effects of in vivo radiation exposure to single bone on bone microarchitecture in the femur 12 weeks post-irradiation. (a) Representative
reconstructed images of μCT scans showing the trabecular and cortical bone at the femur and (b) tBMD. Differences in (c) BS/BV, (d) BV/TV, (e) Tb. Th,
(f) Tb.N, and (g) Tb.Sp. The cortical bone in (h) Ct.Th. (i) Cortical porosity. Data were presented as means ± standard deviations, where *P< 0.05 (n= 16/group)
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39.0 % (P < 0.05) at the irradiated femur compared
with control (Fig. 1g). Bone microarchitecture of the
cortical femur changed slightly with no differences
observed (Fig. 1a, h), but the cortical porosity increased by
17.9 % (P < 0.05) and 13.8 % (P < 0.05), respectively, at the
contralateral and irradiated femur relative to control
(Fig. 1i).
The decreasing of bone mass and biomechanical quality
after single radiation
One week after irradiation, body weight began to decline
(−10.7 %, P > 0.05) and continued to decline rapidly
(−20.7 %, P < 0.05) at 2 weeks after irradiation. However,
at 3 weeks after irradiation, body weight increased, andno changes were observed in body weight between two
groups since 5 weeks after irradiation (Fig. 2a). The max
loading condition of the femur was slightly reduced at
2 weeks, but significantly reduced at 12 weeks after ir-
radiation, and decreased by 15.6 % (P > 0.05) and 32.6 %
(P < 0.05) at the contralateral and irradiated femur rela-
tive to the control femur (Fig. 2b). Bone mineral density
(BMD) of the femur, determined by dual-energy X-ray
absorptiometry (DXA), was reduced in the contralat-
eral and irradiated femurs at 12 weeks post-
irradiation and were significantly decreased by 7.1
and 8.8 % (P < 0.05), respectively, when compared to
the control femur. BMD of the tibia was decreased by
6.0 and 8.5 % (P < 0.05), respectively, at the contralat-
eral and irradiated tibia compared to the control tibia
Fig. 2 Effects of in vivo radiation exposure to single bone on (a) body weight, (b) the maximum loading of the femur at 2 weeks and at 12 weeks,
(c) bone mineral density (BMD) of the femur and tibia, and (d, e) H&E sections of the tibia at 2 and 12 weeks are presented. (f, g) Oil red O sections of
the tibia at 2 and 12 weeks are presented. Data were presented as means ± standard deviations, *P < 0.05, **P < 0.01 and ***P < 0.001 (n = 8/group)
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bone volume in the tibia, where no differences were
observed at 2 weeks (Fig. 2d), decreased significantly
in the contralateral and irradiated tibia at 12 weeks
compared with control (Fig. 2e). The adipocyte area
in the bone marrow of the contralateral and irradi-
ated tibia increased significantly at 2 and 12 weeks
after irradiation (Fig. 2f, g).The osteoblastogenesis decreased after single radiation
To examine the changes of osteoblast and osteoclast ac-
tivity, histomorphometric analysis was performed on
tartrate-resistant acid phosphatase (ALP) and tartrate-
resistant acid phosphatase (TRAP)-stained sections. The
results showed that the ALP-positive OB.S/BS was de-
creased by 38.5 % (P < 0.01) and 42.3 % (P < 0.01) in the
contralateral and irradiated bone, respectively, relative to
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12 weeks irradiation, the situation became worse, a
51.7 % (P < 0.01) reduction at contralateral and a 50.8 %
(P < 0.01) reduction in irradiated rats (Fig. 3e, f ). The
TRAP-positive OC.S/BS was increased by 4.8 % (P >
0.05) at contralateral and by 19.0 % (P < 0.05) at irradi-
ated group compared to control after 2 weeks (Fig. 3c, d).
After 12 weeks post-irradiation, there were no differences
between the two groups (Fig. 3g, h). ELISA analysis of
bone turnover markers in serum revealed a time-
dependent changes of the serum bone formation marker
osteocalcin (OCN), a 17.3 % (P < 0.05) increase in rats atFig. 3 Effects of in vivo radiation exposure to single bone on (a) ALP-staine
(d) OC.S/BS at 2 weeks. (e) ALP-stained sections and (f) OB.S/BS) at 12 weeks.
presented as means ± standard deviations, where *P < 0.05 and **P < 0.01 (n =
(i) Level of serum OCN at 2 weeks and (j) 12 weeks. (k) Level of serum TRAP a
deviations, where *P < 0.05 (n = 16/group)2 weeks post-irradiation but a 29.9 % (P < 0.05) reduction in
rats at 12 weeks post-irradiation (Fig. 3i, j). The serum
bone resorption marker tartrate-resistant acid phosphatase
5b (TRAP5b) had the same trend with OCN—a 30.0 %
(P < 0.05) increase in irradiated rats at 2 weeks post-
irradiation and a 16.7 % (P > 0.05) reduction in rats at
12 weeks post-irradiation (Fig. 3k, l).
The adipocyte differentiation of BMSCs increased after
single radiation
To evaluate the influence of single irradiation on osteo-
blast/adipocyte differentiation of progenitors because ofd sections and (b) OB.S/BS at 2 weeks. (c) TRAP-stained sections and
(g) TRAP-stained sections and (h) OC.S/BS) at 12 weeks. Data were
8/group). Serum bone marker changed at different time after irradiation.
t 2 weeks and (l) 12 weeks. Data were presented as means ± standard
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irradiation, the expression of Runx2 and PPAR γ was de-
termined in BMSCs at 2 and 12 weeks after irradiation
by real-time PCR and Western blot. Results showed that
the significant decrease of Runx2 (−82.3 % at contralat-
eral, P < 0.01 and −88.0 % at irradiated, P < 0.01) and im-
mediate decline of PPAR γ (−61.8 % at contralateral, P <
0.05 and −48.3 % at irradiated, P < 0.05) after 2 weeks
post-irradiation (Fig. 4a, b), the ratio of Runx2/PPAR γ
decreased by 53.6 % (P < 0.05) in contralateral rats
and markedly decreased by 76.8 % (P < 0.01) in irradi-
ated ones relative to control (Fig. 4c). The protein
level of Runx2 and PPAR γ was similar to the
changes of the messenger RNA (mRNA) expression in
BMSCs (Fig. 4d–f ). After 12 weeks irradiation, the
expression of Runx2 continued to downregulate byFig. 4 The relative mRNA and protein of BMSCs at 2 and 12 weeks after irr
ratio of Runx2/PPAR γ at 2 weeks. The protein expression of (e) Runx2 and
and (i) the ratio of Runx2/ PPAR γ at 12 weeks. The protein expression of (k) Ru
deviations, where *P< 0.05, **P< 0.01, and ***P< 0.001 (n= 4/group)44.1 % (P < 0.05) and 94.5 % (P < 0.001) at contralat-
eral and irradiated, respectively, but the expression of
PPAR γ upregulated sharply about ninefold (P < 0.001)
at contralateral and 13-fold (P < 0.001) at irradiated
relative to control (Fig. 4g, h). Therefore, the ratio of
Runx2/PPAR γ continued to sharply decrease with a
93.9 % (P < 0.001) reduction at contralateral and a
99.0 % (P < 0.001) reduction at irradiated (Fig. 4i).
The protein level of Runx2 and PPAR γ was similar
to the changes in the mRNA expression at 12 weeks
after irradiation (Fig. 4j–l).
Discussion
Retrospective study is a common method to examine
the relationship between radiotherapy and the develop-
ment of bone complications. Although the majority ofadiation. The mRNA expression of (a) Runx2, (b) PPAR γ, and (c) the
(f) PPAR γ at 2 weeks. The mRNA expression of (g) Runx2, (h) PPAR γ,
nx2 and (l) PPAR γ at 12 weeks. Data were presented as means ± standard
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plications following radiotherapy on the skeletal sites
directly exposed to the radiation, bone complications
are often found at sites without radiotherapy, which
often occur later when the symptoms of acute irradi-
ation have disappeared [18–20]. A randomized pro-
spective study found that the high femoral fracture
rate (6.7 % of a total 1716) in breast cancer patients
receiving radiotherapy was not the consequence of
the significant direct radiation exposure of the bone.
However, the mechanism of local radiotherapy result-
ing in this abscopal effect on the non-irradiated skel-
eton remains unclear [21, 22].
Using a rat model, we have obtained evidence that
local irradiation induces a time-dependent deterioration
of both bone quantity (BMD) and quality (strength and
microarchitecture) in the unexposed skeleton. This find-
ing demonstrates that radiation damage to the bone does
not require direct radiation exposure to the bone.
Radiation-induced bone loss has historically been attrib-
uted to the long-term impairment of bone formation
[23–28]. A rapid increase in osteoclastogenesis has been
previously reported 1 week after body irradiation [29, 30].
Consistent with these reports, osteoclast number in-
creased in the trabecular bone of our model at 2 weeks
post-irradiation. Furthermore, the level of TRAP in the
rat serum also increased after 2 weeks irradiation. Al-
though osteoblast number in the trabecular bone de-
creased, the level of OCN in the serum was increased
at 2 weeks post-irradiation, suggesting that radiation
exposure did not compromise the coupling time of re-
sorption and formation immediately after irradiation,
so there were no obvious changes in the bone ob-
served 2 weeks post-irradiation. This differed in com-
parison to the changes seen in some irradiation mouse
models [29]. Interestingly, osteoclastogenesis in the ir-
radiated rats was comparable to the control at 12 weeks
post-irradiation. However, osteoblastogenesis in the
trabecular bone was significantly suppressed with a
reduced level of OCN in the serum 12 weeks post-
irradiation. These results indicated that the balance be-
tween bone formation and bone resorption was
altered, supporting the long-standing notion that ioniz-
ing radiation impairs bone formation in the late stage
after irradiation [23–27, 30]. Additionally, a decrease
in body weight was observed after local radiation,
which was thought to be an acute irradiation effect of
the stomach and intestine, leading to a reduction in
body weight because of less feeding and loss of fat
mass [31].
In addition to the downregulation of osteoblastic bone
formation in vivo, dynamic bone slices revealed promo-
tion of marrow adiposity, which was demonstrated by a
continuous increase in the number of adipocytes afterirradiation. A reciprocal relationship has been identified
clinically between marrow adiposity and bone volume in
cancer patients treated with radiotherapy [13, 32]. Con-
sistent with these clinical findings, we reported a near
2.4-fold and 1.8-fold increase in marrow adiposity in the
irradiated and contralateral tibia, respectively, 2 weeks
after irradiation. Jia has previously reported rapid absco-
pal suppression of the bone marrow stromal cell popula-
tion in mice after abdominal irradiation [33]. The bone
marrow stroma hosts progenitors of bone-forming and
bone-resorbing cells and regulates the survival and func-
tion of these progenitors and their progeny [34]. Despite
no observed changes in osteoblast number after 2 weeks
irradiation, the increase in adipocyte numbers might
have exhausted the BMSC pool via an adipogenic lineage
commitment switch, thus, leading to the decrease in
osteoblast number observed in the current model at
later time points. To further confirm this hypothesis, we
detected the relative mRNA and protein expression
levels of Runx2 and PPAR γ in BMSCs, which are im-
portant in determining the balance of BMSC differenti-
ation into osteoblasts and adipocytes, respectively [35].
Runx2 is a crucial marker that determines the differenti-
ation of BMSCs into osteoblasts and affects gene expres-
sion of downstream factors such as ALP, OCN, and
osteopontin (OPN) [36]. PPAR γ regulates fatty acid
storage, and the genes activated by PPAR γ stimulate
lipid uptake and adipogenesis by fat cells. PPAR γ
knockout mice fail to generate adipose tissue when fed a
high-fat diet [37].
In the current model, the expression of Runx2 and
PPAR γ was clearly downregulated 2 weeks post-
irradiation and the ratio of Runx2/PPAR γ was also
decreased. This was further changed at 12 weeks post-
irradiation, whereby the expression of Runx2 was down-
regulated more significantly, the expression of PPAR γ
was upregulated and the ratio of Runx2/PPAR γ de-
creased sharply. It is clear that this marrow defect is
strongly associated with bone loss and might lead to in-
creased fracture risk [18, 30, 38].
Conclusions
To conclude, the etiology of radiation-induced skeletal
complications appears multifactorial and time-dependent.
In the current single femur and tibia irradiation model,
osteoblast activation, decreased osteogenic potential, and
increased marrow adiposity, might be critical for bone
complications after irradiation. The reason why non-
irradiated BMSCs demonstrate identical changes to those
in the irradiated bone marrow is clearly of interest. Fur-
ther studies are necessary to assess bone marrow changes
at the cellular level and to examine the developmental in-
fluences of BMSCs after irradiation at both the irradiated
and non-irradiated bone sites.
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